The agonism and synergistic potentiation of weak partial agonists by triethylamine in α1-adrenergic receptor activation: Evidence for a salt bridge as the initiating process

Molecular Pharmacology

Volumn 53, Issue 4, 1998, Pages 766-771

  Porter, James E ^a   Edelmann, Stephanie E ^b   Waugh, David J ^a   Piascik, Michael T ^b   Perez, Dianne M ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR STIMULATING AGENT; PRAZOSIN; TRIETHYLAMINE;

ANIMAL CELL; ARTICLE; COMPETITIVE INHIBITION; CONCENTRATION RESPONSE; DRUG ANTAGONISM; DRUG POTENTIATION; DRUG RECEPTOR BINDING; LIGAND BINDING; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; SECOND MESSENGER; SITE DIRECTED MUTAGENESIS;

EID: 0031958221     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.53.4.766     Document Type: Article

References (18)

1. Altenbach C, Yang K, Farrens DL, Khorana HG, and Hubbell WL (1996) Structural features and light-dependent changes in the cytoplasmic interhelical E-F loop region of rhodopsin: a site-directed spin labeling study. Biochemistry 35:12470-12478.
2. Bradford MM (1976) A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
3. 2-adrenergic receptors. FASEB J 6:832-839.
4. Farahbakhsh ZT, Ridge KD, Khorana HG, and Hubbell WL (1995) Mapping light-dependent structural changes in the cytoplasmic loop connecting helices C and D in rhodopsin: a site-directed spin labeling study. Biochemistry 34:8812-8819.
5. Kenakin TP (1993) Competitive antagonism, in Pharmacologic Analysis of Drug-Receptor Interaction (Kenakin TP, ed) pp 315-318, Raven Press, New York.
6. Leppick RA, Miller RC, Eck M, and Paquet J-L (1994) Role of acidic amino acids in the allosteric modulation by gallamine of antagonist binding at the m2 muscarinic acetylcholine receptor. Mol Pharmacol 45:983-990.
7. 1-adrenergic receptor subtypes. Mol Pharmacol 46: 929-936.
8. Multulsky HJ and Ransnas LA (1987) Fitting curves to data using nonlinear regression: a practical and nonmathmatical review. FASEB J 1:365-374.
9. 1d-adrenergic receptor cDNA. Mol Pharmacol 40:876-883.
10. 1b-adrenergic receptor is initiated by disruption of an interhelical salt bridge constraint. J Biol Chem 271:26318-28323.
11. Robinson PR, Cohen GB, Zhukovsky EA, and Oprian DD (1992) Constitutively active mutants of rhodopsin. Neuron 9:719-725.
12. a. Proc Natl Acad Sci USA 88:3079-3083.
13. Samama P, Cotecchia S, Costa T, and Lefkowitz RJ (1993) A mutation-induced activated state of the β2-adrenergic receptor. J Biol Chem 268:4625-4636.
14. Sambrook J, Fritsch EF, and Maniatis T (1989) Site-directed mutagenesis of cloned DNA, in Molecular Cloning: A Laboratory Manual (Nolan C, ed) pp 15.63-15.65, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
15. A receptors. Trends Pharmacol Sci 16:162-168.
16. Strader CD, Fong TM, Tota MR, Underwood D, and Dixon RAF (1994) Structure and function of G protein-coupled receptors. Annu Rev Biochem 63:101-132.
17. Subramaniam S, Gerstein M, Oesterhelt D, and Henderson R (1993) Electron diffraction analysis of structural changes in the photocycle of bacteriorhodopsin. EMBO J 12:1-8.
18. Volle RL and Koelle GB (1969) Ganglionic stimulating and blocking agents, in The Pharmacological Basis of Therapeutics (Goodman LS and Gilman A, eds) pp 578-595, Macmillan, Toronto.